Skip to main content

Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

47.81 -0.22 (-0.46%)
Streaming Delayed Price Updated: 9:30 AM EST, Dec 27, 2024 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
May 21, 2007
Form 4
Source: SEC/Edgar
May 21, 2007
Form 3
Source: SEC/Edgar
May 16, 2007
Form 4
Source: SEC/Edgar
May 16, 2007
Form 4
Source: SEC/Edgar
May 16, 2007
Form 4
Source: SEC/Edgar
May 15, 2007
Form 4
Source: SEC/Edgar
May 15, 2007
Form 4
Source: SEC/Edgar
May 15, 2007
Form 4/A
Source: SEC/Edgar
May 15, 2007
Form 4
Source: SEC/Edgar
May 15, 2007
Form 4
Source: SEC/Edgar
May 15, 2007
Form 4
Source: SEC/Edgar
May 15, 2007
Form 4
Source: SEC/Edgar
May 08, 2007
Form 4
Source: SEC/Edgar
April 30, 2007
Form 4
Source: SEC/Edgar
April 23, 2007
Form 4
Source: SEC/Edgar
April 18, 2007
Form 4
Source: SEC/Edgar
April 16, 2007
Form 4
Source: SEC/Edgar
April 11, 2007
Form 4
Source: SEC/Edgar
April 09, 2007
Form 4
Source: SEC/Edgar
April 04, 2007
Form 4
Source: SEC/Edgar
April 03, 2007
Form 4
Source: SEC/Edgar
March 27, 2007
Form 4/A
Source: SEC/Edgar
March 27, 2007
Form 4
Source: SEC/Edgar
March 27, 2007
Form 4
Source: SEC/Edgar
March 27, 2007
Form 4
Source: SEC/Edgar
March 22, 2007
Form 4
Source: SEC/Edgar
March 22, 2007
Form 4
Source: SEC/Edgar
March 20, 2007
Form 4
Source: SEC/Edgar
March 20, 2007
Form 4
Source: SEC/Edgar
March 19, 2007
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.